Profile

Antiverse

Antiverse is building a world-first computational antibody drug discovery platform. They combine in-house lab expertise with state of the art machine learning to predict antibody-antigen binding and provide antibody drug candidates in one day.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology

Website www.antiverse.io/

Associated Team Members

Blog

The New Normal – A Day with Midven’s Investment Director,...

The New Normal – A Day with Midven’s Investment Director, Gio. Earlier this year,...

read more

The Midven Experience: Oneskee

In September last year, Warwickshire based snow sports apparel brand Oneskee, received funding from...

read more

More Companies in Medical / Biotechnology

Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now

×